- Home
- FDS vs PODD Comparison
FDS vs PODD Comparison
Compare FDS & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FDS | PODD |
|---|---|---|
| Founded | 1978 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.0B | 22.1B |
| IPO Year | 1996 | 2007 |
Fundamental Metrics
Financial Performance| Metric | FDS | PODD |
|---|---|---|
| Price | $293.36 | $298.29 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 11 | 19 |
| Target Price | $316.30 | ★ $366.58 |
| AVG Volume (30 Days) | ★ 758.0K | 644.6K |
| Earning Date | 12-18-2025 | 02-19-2026 |
| Dividend Yield | ★ 1.50% | N/A |
| EPS Growth | ★ 12.60 | N/A |
| EPS | ★ 15.72 | 3.45 |
| Revenue | $2,360,702,000.00 | ★ $2,521,800,000.00 |
| Revenue This Year | $6.43 | $32.55 |
| Revenue Next Year | $5.34 | $20.50 |
| P/E Ratio | ★ $18.63 | $85.30 |
| Revenue Growth | 5.88 | ★ 27.11 |
| 52 Week Low | $250.50 | $230.05 |
| 52 Week High | $477.92 | $354.88 |
Technical Indicators
Market Signals| Indicator | FDS | PODD |
|---|---|---|
| Relative Strength Index (RSI) | 56.40 | 51.83 |
| Support Level | $280.01 | $278.79 |
| Resistance Level | $295.36 | $290.60 |
| Average True Range (ATR) | 8.53 | 6.02 |
| MACD | -0.20 | 1.80 |
| Stochastic Oscillator | 66.52 | 94.52 |
Price Performance
Historical ComparisonAbout FDS FactSet Research Systems Inc.
FactSet provides financial data and portfolio analytics to the global investment community. The company aggregates data from third-party data suppliers, news sources, exchanges, brokerages, and contributors into its workstations. In addition, it provides essential portfolio analytics that companies use to monitor portfolios and address reporting requirements. Buy-side clients (including wealth and corporate clients) account for over 80% of FactSet's annual subscription value. In 2015, the company acquired Portware, a provider of trade execution software. In 2017, it acquired BISAM, a risk management and performance measurement provider. In 2022, it completed its purchase of CUSIP Global Services.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.